共 12 条
[1]
Fahn S, Elton RL, Recent development in Parkinson's disease, 2, pp. 153-164, (1987)
[2]
Parkinson Study Group. Effect of deprenyl on the progression of disability in early Parkinson's disease, N Engl J Med, 321, pp. 1364-1371, (1989)
[3]
Parkinson Study Group. Assessment of the short‐term tolerability of lazabemide (RO 19‐6327) in untreated Parkinson's disease [Abstract], Mov Disord, 7, pp. 293-294, (1992)
[4]
Goetz CG, Olanow CW, Koller WC, Et al., Adrenal medullary transplants to the striatum of patients with advanced Parkinson's disease: multicenter study, N Engl J Med, 320, pp. 337-341, (1989)
[5]
Martinez-Martin P, Gil-Nagel A, Gracia M, Et al., Unified Parkinson's Disease Rating Scale characteristics and structure, Mov Disord, 9, pp. 76-83, (1994)
[6]
Van Hilten JJ, Van der Zwan AD, Zwinderman AH, Roos RAC. Rating impairment and disability in Parkinson's disease: evaluation of the Unified Parkinson's Disease Rating Scale, Movement Disorders, 9, pp. 84-88, (1994)
[7]
Richards M, Marder K, Cote L, Mayeux R, Interrater reliability of the Unified Parkinson's Disease Rating Scale motor examination, Mov Disord, 9, pp. 89-91, (1994)
[8]
Stebbins GT, Goetz CG, Flourney T, Unified Parkinson's Disease Rating Scale: reliability and factorial validity, Ann Neurol, 30, (1991)
[9]
Parkinson Study Group, Datatop operations manual, (1989)
[10]
Siegel S, Castellan NJ, Nonparametric statistics for the behavioral sciences, (1988)